Introduction
Viral hepatitis remain a significant public health issue throughout the world including our country (1) . Hepatitis B virus (HBV) infection is a common and severe inflammatory disease of the liver with a wide clinical spectrum from asymptomatic carrier state to chronic hepatitis and fulminant hepatitis (2) . Hepatitis D virus (HDV) is a defective virus which may cause disease only in individuals with HBV infection (3) . Worldwide, approximately more than 15 million HBV carriers are infected with HDV. Our country is located in an intermediate endemic area for HDV (4, 5) .
When the studies performed regarding hepatitis delta in our country are evaluated, it is observed that anti-HDV positivity is present at a rate of 20% in patients with chronic hepatitis and at a rate of 4.9% in inactive hepatitis B carriers (6) .
In this study, it was aimed to determine anti-HDV positivity in inactive hepatitis B carriers and chronic hepatitis B (CHB) patients in our hospital and to provide contribution to the data on the seroprevalence of hepatitis delta in our province.
Material and Methods
We retrospectively evaluated the hospital records of 547 HBsAg-positive patients who were admitted to the infectious disease outpatient clinic between July 2012 and October 2013. According to the American Association for the Study of Liver Anti-HDV was studied using ELISA (DIA.PRO, Italy), ELX 50 bioelisa washer and ELX 800 bioelisa reader. HDV RNA extraction from plasma or serum samples of the patients was performed automatically in EZ1 Advanced (QIAGEN, Germany) device using EZ1 Virus Mini Kit v2.0 (QIAGEN, Germany). HDV RNA amount (viral load) was studied in Real-Time PCR device (ROTOR GENE 6000, CORBETT Research Pty Ltd, Austria) according to the recommendations of the manufacturer.
Results
Three hundred and eight (56.3%) of the patients were males and 239 (43.7%) were females. The mean age was 48.52±12.38 years. Anti-HDV positivity was determined in 5 (0.9%) of the 547 HBsAg-positive patients (204 CHB patients and 343 inactive HBsAg carrier). HDV-RNA positivity was determined in all anti-HDV-positive patients. While anti-HDV positivity was determined in 3 (0.87%) of 343 inactive HBsAg carriers, 2 (1%) of 204 CHB patients were found to be anti-HDV-positive.
Discussion
While the prevalence of HDV infection is less than HBV infection, the clinical feature caused by HDV infection is severe (7) . HDV infection is a critical problem in our country, particularly in Eastern and Southeastern Anatolia. In recent years, HDV infection is decreasing throughout the country, however, the positivity rate still remains to be critical (6) . Anti-delta IgG positivity was determined at a rate of 2.7% in a nationwide community-based survey on the prevalence of viral hepatitis in our country (13, 14) . In our study, anti-HDV positivity was determined in 5 (0.9%) of the 547 HBsAg-positive patients in Eskisehir province. When the data of our province was evaluated, it was seen that anti-HDV positivity was lower than general average of our country. This was attributed to intensity of anti-HDV positivity especially in the East and Southeast regions of our Turkey and lower rates of anti-HDV positivity reported in the Central Anatolia Region including also our province.
Anti-delta positivity can vary in different patient groups. In a meta-analysis performed by Degertekin et al. in our country, anti-HDV positivity rate in inactive hepatitis B carriers between 1980 and 2005 was determined to be 4.9%. In the same study, it was reported that this rate decreased to 2.9% after 2001 (6). Anti-HDV positivity in inactive hepatitis B carriers was determined to be 6.3% in İzmir by Yurtsever et Kaya et al. (9, [15] [16] [17] [18] . In a study performed by Us et al. in Eskişehir province between 1995 and 1997, anti-HDV positivity in 50 inactive hepatitis B carriers was determined to be 2% (19) . In our study, this rate was determined to be 0.87% and it was observed that seroprevalence of hepatitis delta in inactive hepatitis B carriers decreased within years in our region.
Frequency of HDV infection in patients with CHB was determined to be 24.8% in 145 patients by Guducuoglu et al. in Van, 45 (19) . In our study, anti-HDV positivity was determined in 2 (1%) of 204 patients with chronic hepatitis B. A decrease was determined in seroprevalence of HDV infection in patients with CHB in our province within years consistently in accordance with all regions of our country.
In conclusion, anti-HDV positivity determined in CHB patients and inactive HBsAg carriers decreased within years in Eskişehir province. However, our country is located in an intermediate endemic area for HDV and regional data may change due to immigrations, therefore, the presence of hepatitis D infection must be definitely investigated in HBsAg carriers.
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